BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 35954274)

  • 1. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR Beta/Delta and the Hallmarks of Cancer.
    Wagner N; Wagner KD
    Cells; 2020 May; 9(5):. PubMed ID: 32375405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
    Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R
    Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer.
    Psilopatis I; Vrettou K; Troungos C; Theocharis S
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review.
    Grygiel-Górniak B
    Nutr J; 2014 Feb; 13():17. PubMed ID: 24524207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.
    Tenenbaum A; Motro M; Fisman EZ
    Cardiovasc Diabetol; 2005 Sep; 4():14. PubMed ID: 16168052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N; Vamecq J
    Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
    Knapp P; Jarzabek K; Błachnio A; Zbroch T
    Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new insight into the treatment of diabetes by means of pan PPAR agonists.
    Chandra A; Kaur P; Sahu SK; Mittal A
    Chem Biol Drug Des; 2022 Dec; 100(6):947-967. PubMed ID: 34990085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
    Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
    Menendez-Gutierrez MP; Roszer T; Ricote M
    Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.
    Ibabe A; Herrero A; Cajaraville MP
    Toxicol In Vitro; 2005 Sep; 19(6):725-35. PubMed ID: 15964169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of PPARs in Disease.
    Wagner N; Wagner KD
    Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
    Mirza AZ; Althagafi II; Shamshad H
    Eur J Med Chem; 2019 Mar; 166():502-513. PubMed ID: 30739829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH; Roufogalis BD
    Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
    Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.